Consortium organization

The organizational structure of Lifelong VISION is designed to promote (i) transparent and collaborative decision-making at all levels, (ii) efficient progress monitoring and reporting, (ii) fruitful interactions with external experts and stakeholders, and (iv) optimal embedding at the participating institutes.

 

 

The organizational structure consists of the following Consortium Bodies:

  1. Executive Board
  2. Coordinator
  3. Project Support Office

Furthermore, the following advisory boards and councils shall exist:

  1. Scientific Advisory Board (SAB)
  2. Institutional Board (IB)

The people involved

The program is organized in pillars and platforms. Each of those has a page the team members:

For an overview of everyone involved please visit our team page.

go to main content

Consortium organization

The organizational structure of Lifelong VISION is designed to promote (i) transparent and collaborative decision-making at all levels, (ii) efficient progress monitoring and reporting, (ii) fruitful interactions with external experts and stakeholders, and (iv) optimal embedding at the participating institutes.

learn more

Gene-based therapy Pillar 1

To design and refine truly personalized, innovative and effective treatments for visually impaired individuals.

read more

Pathway-based therapy Pillar 2

New therapeutic approaches for AMD and IRD.

read more

Cell-based therapy Pillar 3

Regenerative medicine approaches for retinal diseases. 

read more

Model systems Platform A

Development of complex models to assess therapeutics in vitro.

read more

Patient profiling Platform B

A datadriven approach to define intervention-specific disease signatures.

read more